Select your country to display the correct information / Seleziona il tuo paese per visualizzare le informazioni corrette
INFOLINE  +41(0)840 888 555

NIPT, the first pre-birth non-invasive test to assess the risk of trisomy 21, 13 and 18

Genico provides mothers with the opportunity to perform NIPT;, a new non-invasive test to evaluate the risk of trisomy 21 (Down's syndrome), 13 e 18 (Edwards's and Pätau's syndromes) in the fetus. The test is carried out on a sample of the mother's blood. The procedure is therefore completely risk-free for the baby and it is reliable in more than 98% of cases.

The decision to undergo NIPT; is subject to medical advice from the gynecologist, and the test can be carried out from the 9th week of pregnancy onwards (week 9+0).

Furthermore, the mother has to be in one of the following conditions:
  • Advanced age for pregnancy
  • Abnormal outcome of sonographic test for trisomy 21, 13 or 18
  • Abnormal serum markers for trisomy 21, 13 or 18
  • Family history or previous pregnancy with trisomy 21, 13 or 18
  • Further clinical reasons (according to medical evaluation)
Contact us for more information, or ask your gynecologist.
Our advisors will be happy to answer
your questions with no obligation
to you.
To contact an advisor, click here
Send your data, you will be contacted as soon as possible
By clicking 'send' you authorize Genico treating your personal data